Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Newborn Screening Saves Lives Reauthorization, Reforms to the Military Health System / TRICARE Exceptional Family Member Program, Stopping Military Medical Personnel Billet Reductions, VACCINES Act - Inclusion in Coronavirus (COVID-19) Legislative Vehicles, FY21 Labor, Health and Human Services, and Education Appropriations: CDC/NIH Firearm Injury and Mortality Prevention Research, HRSA Emergency Medical Services for Children, HRSA Pediatric Subspecialty Loan Repayment Program, CDC National Center for Birth Defects and Developmental Disabilities, ACF Child Abuse Prevention and Treatment Act Grants, CDC Global Immunization Programs, ASPR Pediatric Disaster Care Pilot Program, HRSA Pediatric Mental Health Care Access, HRSA Screening and Treatment for Maternal Depression, NIH Adolescent E-Cigarette Cessation Research, SAMHSA Reducing Underage Drinking Through Screening, Brief Intervention, and Referral to Treatment, FY21 Agriculture, Rural Development, and FDA Appropriations: USDA/FNS WIC Breastfeeding Peer Counselor Program and FDA Pediatric Device Consortia, Healthy Start Reauthorization, Families First Coronavirus Response Act (HR 6201), Coronavirus Aid, Relief, and Economic Security Act (S 3548), Child Abuse Prevention and Treatment Act reauthorization, CAPTA Plans of safe care grants, Family First Prevention Services Act implementation, Maternal, Infant, and Early Childhood Home Visiting Program funding, Gun violence prevention research funding, Sudden Unexpected Infant Death (HR 2271 / S 1130), STURDY Act (HR 2211 / S 1902), Safe Sleep for Babies Act (HR 3172 / S 1767), Child product safety, Issues related to the COVID-19 pandemic and providing supports for the child welfare community, Funding for Child Care and Development Black Grant, Providing Americans Insured Days of Leave Act, Infant sleep product safety, Magnet Injury Prevention, Lead exposure, Regulation of air pollutants, Paid Family Leave, Climate change, TSCA Implementation, IHS Funding, Indian Health Service Health Professions Tax Fairness Act (HR 6448 / S 2871), REMOTE Act, Standards in CBP Custody, S. 2135, Standards in ICE Family Detention, Standards in ORR Custody, Public Charge, Child Nutrition Reauthorization/WIC, SNAP, Mental Health for Children, OTC Drug Reform, Requirements for airplane EMKs, H.R. 6, DREAM Act, Family Separation and Detention, Fair Day in Court for Kids Act, Menu Labeling, Nutrition Facts Label, Equality Act, HR 5, CARE for Families Act HR 3107, WIC Act, Keep Families Together Act, Breastfeeding Peer Counseling Program, Public Health Preparedness and Response, Medical Nutrition Equity Act, Therapeutic Fraud Prevention Act, Funding for Mental Health Access Grants, Funding for HRSA Maternal Depression Grants, Research for Pregnant and Lactating Women, Palliative Care and Hospice Education and Training Act (S. 2080), Medical Deferred Action, Access to Healthy Food for Young Children Act of 2019 (S. 2501), H.R. 3246, Traveling Parents Screening Consistency Act of 2019, Friendly Airports for Mothers Expansion (FAME) Act, Healthy Meals for Opioid-Affected Kids and Kids Raised by Grandfamilies , 21st Century Cures 2.0, Dietary Guidelines, Families First Coronavirus Response Act, Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pediatric Disaster Care Pilot Program, Child Poverty, Funding for the Emergency Medical Services for Children (EMSC) Program, Funding for Pediatric Device Consortia, PUMP for Nursing Mothers Act, S. 3170, 12-Month Continuous Medicaid/CHIP Eligibility, Medicaid Work Requirements, Medicaid Eligibility Proposed Rule, Medicaid Block Grants, Medicaid Per Capita Caps, Section 1115 Medicaid Waivers, Increase to Medicaid FMAP During COVID-19, Establish an automatic FMAP increase tied to state economic indicators, HR 6159, the Kids Access to Primary Care Act, Medicaid Maintenance of Effort (MOE) Protections, Comprehensive Access to Robust Insurance Now Guaranteed (CARING) for Kids Act (H.R.6151), H.R.6098 to Expand State CHIP Eligibility, Delaying the CHIP FMAP Decrease, Medicaid Fiscal Accountability Rule, Maternal Health, Expanding Medicaid to 12 Months Post-Partum, Medicaid Premiums and Cost Sharing, Medicaid Payment for Eligibility Workers. Recoupment of the Payment Error Rate Measurement (PERM), Expanding the use of Telehealth in Medicaid/CHIP/Private Insurance, Allow for the home and other secure locations as originating (patient) and distant (provider) sites in telehealth, Waive telehealth cost-sharing for patients in telehealth, Pay for telehealth care visits at parity with that of in-person visits, Allow telehealth care for both new and established patients, Expanding Capacity for Health Outcomes (ECHO) Act of 2019 (S 1618/HR 5199), Including Preventive Medicine Service Codes to be Eligible for Telehealth, Public Health and Social Services Emergency Funding, Financial Relief to Medicaid Providers, COVID-19 Response, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), Families First Coronavirus Response Act (H.R. 6201), Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748)Proposed Repeal of Medicaid Access Rule , Medicaid Payment Parity, Reversing the Youth Tobacco Epidemic Act (H.R. 2339), EMPOWER for Health Act (H.R. 2781), Investment in Tomorrow's Pediatric Health Care Workforce Act (S. 2443), Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997), National Institutes of Health Appropriations, Title VII Health Professions Programs Appropriations, NIH Environmental influences on Child Health Outcomes Appropriations, Pediatric Subspecialty Loan Repayment Program Appropriations, Food Allergy Appropriations Initiatives, CARES Act, Protecting Cures Act of 2020 (H.R. 6417), Fetal Tissue Research

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Immigration & Customs Enforcement (ICE), U.S. Customs & Border Protection, Homeland Security - Dept of (DHS), Health & Human Services - Dept of (HHS), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Agriculture - Dept of (USDA), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), Housing & Urban Development - Dept of (HUD), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), U.S. Agency for International Development (USAID), U.S. Citizenship & Immigration Services (USCIS), Health Resources & Services Administration (HRSA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes